CD34^＋ HSC Hu-NSG Mice Model

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

NSG engrafted with human CD34+ hematopoietic stem cells (HSC) can develop multi-lineage human immune cells, and is effective in vivo model for immunology or CAR-T therapy efficacy research and infectious disease research. The HuCD34-NSG mouse from Creative Biolabs is a research-ready mouse model with a human-like immune system created by adoptive transfer of CD34+ HSC cells. CD34+ mice are in our inventory and can be shipped to your institution immediately or for efficacy studies at our institution.

Brief Introduction

CD34+ humanized mouse is a model in which human umbilical cord blood and HSC are transplanted into NSG mice. After HSC transplantation, it can be colonized in mouse bone marrow and continuously produce various types of hematopoietic or immune cells, such as T cells, B cells, NK cells, myeloid cells, etc. Since its immune cells are developed in mice and are tolerant of mice, GvHD will not appear, making it an ideal choice for long-term research.

Key Features

By running NHP toxicology and rodent studies in the same facility, time can be saved and logistics can be simplified.
Reduce development time and improve cost-effectiveness through on-site pathology/histopathology services (including IHC, ICC and IF)
Start research quickly to get reliable results quickly. The research can be started within 4 weeks, and the duration of the research can be optimized to suit the needs of customers and projects
A cost-effective way to guide your GLP research. Our exploratory non-GLP toxicology screening usually only costs a small part of the cost of GLP research.

Hu-CD34 NSG Humanization Process

Female mice were injected with human hematopoietic stem cells (hu-CD34 +). Approximately 2 months after the injection, the implantation of mature human leukocytes (hCD45 +) was confirmed.

Engraftment of hematopoietic stem cells (HSCs) into NSG mice.

Fig.1 Engraftment of hematopoietic stem cells (HSCs) into NSG mice.

Hu-CD34 NSG & PDX Capabilities

Our NSG mouse models have a higher degree of immunodeficiency. It lacks NK cells while lacking T cells and B cells, and innate immunity is compromised. The NSG model is very suitable for human tumor cell transplantation (CDX), human tumor tissue transplantation (PDX) for immune reconstruction.

Highlights

Convenient - HuCD34-NCG PDX mice can be used for research and can express human immune cells
Consistent - every mouse has been tested for humanity
Stable - the implantation of hematopoietic cells provides a research platform for further research
License - free-no additional licensing fees or royalties

Establishment of Hu-CD34 NSG PDX model.

Fig.2 Establishment of Hu-CD34 NSG PDX model.

Applications

Hu-CD34-NSG is an ideal choice for long-term in vivo research in the field of immunology and cell therapy because they have a life span of more than 12 months after CD34+ implantation. Specifically, they can be used to evaluate the CAR-T therapies including but not limited to: monitor CAR-T distribution in vivo, determine CAR-T persistency, and monitor Cytokine Release Syndromes.

For more detailed information, please feel free to contact us or directly sent us an inquiry.

Key Updates

NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER

NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION

NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY